# EndoSphere

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endosphere

- Industry: Medical Devices & Equipment
- Headquarters: Columbus, US
- Website: www.endo-sphere.com
- Latest round: Series A (Jun 1, 2011)
- Investors on record: 4

## About

EndoSphere is a health-focused company that specializes in developing innovative therapies designed to enhance circulation, metabolism, and overall wellness for both healthcare professionals and individual consumers.EndoSphere, founded in 2006 and headquartered in Columbus, US, is dedicated to providing advanced health solutions. The company has completed a total of 3 deals, with the most recent one occurring on June 18, 2015, raising USD 2.00 mn. The company was established by Kenneth Binmoeller, who has a notable history in the healthcare sector.EndoSphere specializes in innovative solutions aimed at enhancing health and wellness through its core product offerings. The company primarily focuses on advanced therapies that leverage proprietary technologies to address issues related to circulation, metabolism, and overall body function. These products cater to a diverse clientele, including healthcare professionals and individual consumers seeking to improve their well-being. Their applications extend to various conditions, making them relevant in clinical settings and personal health management. EndoSphere's products are marketed across several geographical regions, including Europe and North America, to meet the growing demand for effective health solutions.EndoSphere generates revenue through a structured business model involving direct sales to consumers and partnerships with healthcare providers and wellness centers. The company offers subscription plans that provide clients with ongoing access to their products and services, ensuring a steady stream of income while fostering customer loyalty. Flagship products are available at competitive pricing, tailored to the needs of both individual users and professionals. The transaction structure typically involves direct engagement with clients, allowing for personalized service and support, solidifying relationships with customers and enhancing the overall value proposition of the company's offerings.EndoSphere plans to leverage its recent venture capital financing of USD 2.00 mn raised in June 2015 to support the launch of new products aimed at enhancing its therapeutic offerings. The company is also targeting expansion into new geographic markets, particularly in Asia and South America, with plans for rollout by 2025. These initiatives will focus on broadening its client base and enhancing service availability, ensuring that EndoSphere meets evolving health needs globally.

## Funding rounds

- Series A, Jun 1, 2011 — Glengary, North Coast Ventures, Broadline Principle Capital, Physician Investment Group

## Investors

- Glengary (https://capitalatlas.ai/funds/glengary) — Series A
- North Coast Ventures (https://capitalatlas.ai/funds/north-coast-ventures) — Series A
- Broadline Principle Capital — Series A
- Physician Investment Group — Series A